Mounjaro becomes India’s top-selling GLP-1 drug as diabetes, weight-loss medicines surge
via The Indian Express https://ift.tt/cByN8QX
The Indian Express
Mounjaro becomes India’s top-selling GLP-1 drug as diabetes, weight-loss medicines surge
Mounjaro maker Eli Lilly leads a fast-growing market that reached Rs 2,333 crore, with injectable GLP-1 medicines now accounting for 86% of sales
September 9, 2026 306
